Advanced Solid Tumors Clinical Trials in Hackensack, New Jersey

7 studies are recruiting for advanced solid tumors in Hackensack, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

    This is a study evaluating the safety, pharmacokinetics, and efficacy of calderasib alone, and calderasib plus other combination therapies in participants with advanced solid tumors with identified kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    John Theurer Cancer Center at Hackensack University Medical Center ( Site 0260), Hackensack, New Jersey
    Locations
    75 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT05067283 on ClinicalTrials.gov

  2. A Study of BG-C477 in Participants With Advanced Solid Tumors

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of BG-C477 alone and in combination with anticancer agents in participants with selected advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    John Theurer Cancer Center Hackensack University Medical Center, Hackensack, New Jersey
    Locations
    59 in total
    Run by
    BeOne Medicines

    See if you can join NCT06596473 on ClinicalTrials.gov

  3. A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

    Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. Solid tumors are cancers mostly in body organs and tissues, not in the blood or other body liquids. The main g…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    John Theurer Cancer Center at Hackensack University Medical Center ( Site 1009), Hackensack, New Jersey
    Locations
    49 in total
    Run by
    Merck Sharp & Dohme LLC

    See if you can join NCT06818643 on ClinicalTrials.gov

  4. A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

    This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Hackensack University Medical Center, Hackensack, New Jersey
    Locations
    17 in total
    Run by
    NextCure, Inc.

    See if you can join NCT06792552 on ClinicalTrials.gov

  5. A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

    To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Hackensack University Medical Center, Hackensack, New Jersey
    Locations
    39 in total
    Run by
    Incyte Corporation

    See if you can join NCT05836324 on ClinicalTrials.gov

  6. Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

    The primary goal of this study is to assess the safety and tolerability of mRNA-4359 administered alone and in combination with pembrolizumab or ipilimumab and nivolumab.

    Stage
    Phase 1
    Ages
    12 and older
    Site
    John Theurer Cancer Center, Hackensack, New Jersey
    Locations
    39 in total
    Run by
    ModernaTX, Inc.

    See if you can join NCT05533697 on ClinicalTrials.gov

  7. A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

    The purpose of this study is to test the safety and efficacy of BMS-986482 alone and as combination therapy in participants with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey
    Locations
    21 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT06697197 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.